The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis
- 1 July 2019
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 145, 104270
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences
- National Heart, Lung, and Blood Institute
This publication has 107 references indexed in Scilit:
- Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemiaOncogene, 2011
- Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancerOncogene, 2011
- Vimentin is a novel AKT1 target mediating motility and invasionOncogene, 2010
- The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell MigrationMolecular Cell, 2010
- The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by AktOncogene, 2009
- Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancerCellular Signalling, 2009
- Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healingAngiogenesis, 2008
- Vascular permeability, vascular hyperpermeability and angiogenesisAngiogenesis, 2008
- Akt1 governs breast cancer progression in vivoProceedings of the National Academy of Sciences, 2007
- Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycinCancer Cell, 2006